Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Yang, Rui ^a   Li, Wei Wei ^b   Hoang, Bang H ^b,c   Kim, Hansoo ^b,d   Banerjee, Debabrata ^b,e   Kheradpour, Albert ^b,f   Healey, John H ^b   Meyers, Paul A ^b   Bertino, Joseph R ^b,e   Gorlick, Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Seoul National University Hospital   (South Korea)

^e RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^f LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; MESSENGER RNA; METHOTREXATE; REDUCED FOLATE CARRIER; TRIMETREXATE; ANTINEOPLASTIC AGENT; CARRIER PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DNA METHYLATION; DOWN REGULATION; FIBROHISTIOCYTOMA; GENE SEQUENCE; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; MULTIPLE DRUG DOSE; NUCLEOTIDE SEQUENCE; PROCESS DEVELOPMENT; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; VALIDATION PROCESS; BIOSYNTHESIS; BREAST TUMOR; DRUG EFFECT; DRUG RESISTANCE; DRUG THERAPY; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 44149098042     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-124     Document Type: Article

References (32)

1. Zhao R Goldman ID Resistance to antifolates Oncogene 2003, 22(47):7431-7457. 10.1038/sj.onc.1206946 14576850
2. Gorlick R Goker E Trippett T Waltham M Banerjee D Bertino JR Intrinsic and acquired resistance to methotrexate in acute leukemia N Engl J Med 1996, 335(14):1041-1048. 10.1056/NEJM199610033351408 8793930
3. Banerjee D Mayer-Kuckuk P Capiaux G Budak-Alpdogan T Gorlick R Bertino JR Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase Biochim Biophys Acta 2002, 1587(2-3):164-173. 12084458
4. Matherly LH Goldman DI Membrane transport of folates Vitam Horm 2003, 66:403-456. 12852262
5. Wong SC Proefke SA Bhushan A Matherly LH Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells J Biol Chem 1995, 270(29):17468-17475. 10.1074/jbc.270.29.17299 7615551
6. Williams FM Flintoff WF Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake J Biol Chem 1995, 270(7):2987-2992. 10.1074/jbc.270.7.2987 7852378
7. Prasad PD Ramamoorthy S Leibach FH Ganapathy V Molecular cloning of the human placental folate transporter Biochem Biophys Res Commun 1995, 206(2):681-687. 10.1006/bbrc.1995.1096 7826387
8. Moscow JA Gong M He R Sgagias MK Dixon KH Anzick SL Meltzer PS Cowan KH Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells Cancer Res 1995, 55(17):3790-3794. 7641195
9. Zhang L Taub JW Williamson M Wong SC Hukku B Pullen J Ravindranath Y Matherly LH Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy Clin Cancer Res 1998, 4(9):2169-2177. 9748136
10. Gorlick R Goker E Trippett T Steinherz P Elisseyeff Y Mazumdar M Flintoff WF Bertino JR Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression Blood 1997, 89(3):1013-1018. 9028333
11. Ma D Huang H Moscow JA Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells Biochem Biophys Res Commun 2000, 279(3):891-897. 10.1006/ bbrc.2000.4019 11162445
12. Guo W Healey JH Meyers PA Ladanyi M Huvos AG Bertino JR Gorlick R Mechanisms of methotrexate resistance in osteosarcoma Clin Cancer Res 1999, 5(3):621-627. 10100715
13. Whetstine JR Flatley RM Matherly LH The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: Identification of seven non-coding exons and characterization of a novel promoter Biochem J 2002, 367(Pt 3):629-640. 1222932 12144527 10.1042/BJ20020512
14. Matherly LH Hou Z Deng Y Human reduced folate carrier: Translation of basic biology to cancer etiology and therapy Cancer Metastasis Rev 2007, 26(1):111-128. 10.1007/s10555-007-9046-2 17334909
15. Zhang L Wong SC Matherly LH Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons Biochem J 1998, 332(Pt 3):773-780. 1219540 9620882
16. Tolner B Roy K Sirotnak FM Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity Gene 1998, 211(2):331-341. 10.1016/S0378-1119(98)00123-1 9602167
17. Williams FM Flintoff WF Structural organization of the human reduced folate carrier gene: Evidence for 5′ heterogeneity in lymphoblast mRNA Somat Cell Mol Genet 1998, 24(3):143-156. 10.1023/ B:SCAM.0000007117.50428.63 10226652
18. Gong M Cowan KH Gudas J Moscow JA Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1) Gene 1999, 233(1-2):21-31. 10.1016/ S0378-1119(99)00166-3 10375617
19. Whetstine JR Matherly LH The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. Basis for tissue-specific gene expression J Biol Chem 2001, 276(9):6350-6358. 10.1074/jbc.M008074200 11078737
20. Whetstine JR Witt TL Matherly LH The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism J Biol Chem 2002, 277(46):43873-43880. 10.1074/jbc.M208296200 12228234
21. Bird A DNA methylation patterns and epigenetic memory Genes Dev 2002, 16(1):6-21. 10.1101/gad.947102 11782440
22. Jones PA Baylin SB The fundamental role of epigenetic events in cancer Nat Rev Genet 2002, 3(6):415-428. 12042769
23. Worm J Kirkin AF Dzhandzhugazyan KN Guldberg P Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells J Biol Chem 2001, 276(43):39990-40000. 10.1074/jbc.M103181200 11509559
24. Moscow JA Connolly T Myers TG Cheng CC Paull K Cowan KH Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines Int J Cancer 1997, 72(1):184-190. 10.1002/ (SICI)1097-0215(19970703)72:1<184::AID-IJC26>3.0.CO;2-I 9212241
25. Li WW Takahashi N Jhanwar S Cordon-Cardo C Elisseyeff Y Jimeno J Faircloth G Bertino JR Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: Identification of ecteinascidin-743 as a potent cytotoxic agent Clin Cancer Res 2001, 7(9):2908-2911. 11555609
26. Dedhar S Hartley D Goldie JH Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction Biochem J 1985, 225(3):609-617. 1144635 3856428
27. Mini E Moroson BA Franco CT Bertino JR Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines Cancer Res 1985, 45(1):325-330. 3855284
28. Sowers R Toguchida J Qin J Meyers PA Healey JH Huvos A Banerjee D Bertino JR Gorlick R mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma Mol Cancer Ther 2003, 2(6):535-541. 12813132
29. Wong SC Zhang L Witt TL Proefke SA Bhushan A Matherly LH Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier J Biol Chem 1999, 274(15):10388-10394. 10.1074/ jbc.274.15.10388 10187828
30. Yang R Kolb EA Qin J Chou A Sowers R Hoang B Healey JH Huvos AG Meyers PA Gorlick R The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate Clin Cancer Res 2007, 13(9):2557-2567. 10.1158/1078-0432.CCR-06-1343 17473184
31. Usadel H Brabender J Danenberg KD Jeronimo C Harden S Engles J Danenberg PV Yang S Sidransky D Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 2002, 62(2):371-375. 11809682
32. Ferreri AJ Dell'Oro S Capello D Ponzoni M Iuzzolino P Rossi D Pasini F Ambrosetti A Orvieto E Ferrarese F Arrigoni G Foppoli M Reni M Gaidano G Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas Br J Haematol 2004, 126(5):657-664. 10.1111/j.1365-2141.2004.05109.x 15327516